Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview
Authors:
- 26 February 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 23 (4) , 267-280
Abstract
Introduction: Epigenetic mechanisms of gene regulatory control play fundamental roles in developmental morphogenesis, and, as more recently appreciated, are heavily implicated in the onset and progression of neoplastic disease, including cancer. Many epigenetic mechanisms are therapeutically targetable, providing additional incentive for understanding of their contribution to cancer and other types of neoplasia. Areas covered: The Jumonji-domain histone demethylase (JHDM) family exemplifies many of the above traits. This review summarizes the current state of knowledge of the functions and pharmacologic targeting of JHDMs in cancer and other neoplastic processes, with an emphasis on diseases affecting the pediatric population. Expert opinion: To date, the JHDM family has largely been studied in the context of normal development and adult cancers. In contrast, comparatively few studies have addressed JHDM biology in cancer and other neoplastic diseases of childhood, especially solid (non-hematopoietic) neoplasms. Encouragingly, the few available examples support important roles for JHDMs in pediatric neoplasia, as well as potential roles for JHDM pharmacologic inhibition in disease management. Further investigations of JHDMs in cancer and other types of neoplasia of childhood can be expected to both enlighten disease biology and inform new approaches to improve disease outcomes.Keywords
Funding Information
- National Cancer Institute (T32-CA190216)
This publication has 182 references indexed in Scilit:
- Protein Complex Interactor Analysis and Differential Activity of KDM3 Subfamily Members Towards H3K9 MethylationPLOS ONE, 2013
- NOTCH1 Nuclear Interactome Reveals Key Regulators of Its Transcriptional Activity and Oncogenic FunctionMolecular Cell, 2012
- H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescenceProceedings of the National Academy of Sciences, 2012
- Histone Demethylase JmjD2A Regulates Neural Crest SpecificationDevelopmental Cell, 2010
- PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progressionNature, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65Proceedings of the National Academy of Sciences, 2009
- Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a / Arf locusProceedings of the National Academy of Sciences, 2009
- Genome-wide Analysis of the H3K4 Histone Demethylase RBP2 Reveals a Transcriptional Program Controlling DifferentiationMolecular Cell, 2008
- JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genesNature, 2007